广东富信科技股份有限公司 证券代码：688662 证券简称：富信科技 公告编号：2025-018 关于召开2024年年度股东会的通知 一、召开会议的基本情况 （一）股东会类型和届次 2024年年度股东会 （二）股东会召集人：董事会 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （三）投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结 合的方式 （一） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 5 月 16 日 14:30:00 召开地点：佛山市顺德高新区(容桂)科苑三路 20 号广东富信科技股份有限 公司三车间五楼多功能会议室 （四）网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 16 日 至2025 年 5 月 16 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联网 投 ...

证券代码：688662 证券简称：富信科技 公告编号：2025-012 广东富信科技股份有限公司 第五届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 广东富信科技股份有限公司（以下简称"公司"）第五届监事会第三次会议 于 2025 年 4 月 23 日在公司办公楼五楼一号会议室以现场与通讯相结合的方式召 开。本次会议通知以及相关材料于 2025 年 4 月 13 日通过书面方式送达全体监事。 本次会议由监事会主席梁竞新召集和主持，应出席监事 3 人，实际出席监事 3 人。本次会议采用现场与通讯相结合的表决方式，会议的召集和召开程序符合 《中华人民共和国公司法》（以下简称"《公司法》"）等法律法规及《广东富 信科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，会议形 成的决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于<2024 年度监事会工作报告>的议案》 1、主要内容：经审议，公司监事会总结 2024 年的工作而形成的《2024 年 度监事会工 ...

证券代码：688662 证券简称：富信科技 公告编号：2025-011 广东富信科技股份有限公司 第五届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广东富信科技股份有限公司（以下简称"公司"）第五届董事会第四次会 议于 2025 年 4 月 23 日在公司办公楼五楼一号会议室以现场与通讯相结合的方式 召开。本次会议通知以及相关材料于 2025 年 4 月 13 日以书面方式送达全体董事。 本次会议由公司董事长刘富林召集和主持，应出席董事 9 人，实际出席董 事 9 人。本次会议采用现场与通讯相结合的表决方式，会议的召集、召开与表决 程序符合《中华人民共和国公司法》（以下简称"《公司法》"）、《广东富信 科技股份有限公司章程》（以下简称"《公司章程》"）的规定，会议形成的决 议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于<2024 年度总经理工作报告>的议案》 1、主要内容：经审议，公司总经理总结 2024 年的工作而形成的《2024 年 度总经理工作报告》 ...

在实施权益分派的股权登记日前公司总股本发生变动的，拟维持每股分 配金额不变，相应调整分配总额，并将另行公告具体调整情况。 本次利润分配方案不触及《上海证券交易所科创板股票上市规则》第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警示的情形。 一、利润分配方案内容 证券代码：688662 证券简称：富信科技 公告编号：2025-014 广东富信科技股份有限公司 2024 年年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股分配比例：A 股每股派发现金股利人民币 0.35 元（含税），不进行 资本公积转增股本，不送红股。 本次利润分配以实施权益分派股权登记日登记的总股本扣除公司回购 专用证券账户中股份数后的股本为基数，具体日期将在权益分派实施公告中明确。 （二）是否可能触及其他风险警示情形 （一）利润分配方案的具体内容 经中审众环会计师事务所（特殊普通合伙）审计，截至 2024 年 12 月 31 日， 广东富信科技股份有限公司（以下简称"公司"）母公司报表中期末未分配利润 ...

Dividend and Profit Distribution - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares, totaling approximately RMB 30,876,584.90 (including tax) based on a total share capital of 88,218,814 shares after accounting for repurchased shares[6]. - The total amount for the proposed cash dividend and share repurchase is RMB 61,368,550.47, which represents 137.97% of the net profit attributable to shareholders for the year 2024[6]. - The proposed profit distribution plan is subject to approval at the 2024 annual shareholders' meeting[7]. Financial Performance - The company has not achieved profitability since its listing, indicating ongoing financial challenges[4]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year 2023, representing a 15% growth compared to the previous year[18]. - The company's operating revenue for 2024 reached ¥515.63 million, an increase of 29.04% compared to ¥399.59 million in 2023[26]. - The net profit attributable to shareholders for 2024 was ¥44.48 million, a significant turnaround from a loss of ¥12.78 million in 2023[26]. - The net cash flow from operating activities increased by 91.68% to ¥100.20 million, up from ¥52.27 million in the previous year[26]. - Basic earnings per share for 2024 were ¥0.52, compared to a loss of ¥0.15 per share in 2023[27]. - The weighted average return on equity rose to 6.79%, an increase of 8.62 percentage points from -1.83% in 2023[27]. - The gross margin for the fiscal year 2023 improved to 35%, up from 30% in the previous year, reflecting better cost management and pricing strategies[18]. Operational Risks and Governance - The company has detailed various operational risks in its report, which investors should review[4]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[10]. - There are no violations of decision-making procedures regarding external guarantees[10]. - The company has not disclosed any special arrangements for corporate governance[8]. - The company emphasizes that forward-looking statements in the report do not constitute substantive commitments to investors, highlighting investment risks[9]. Research and Development - The company is investing 50 million RMB in R&D for new technologies aimed at improving product efficiency and sustainability[18]. - Research and development expenses accounted for 6.55% of operating revenue, a decrease of 1.34 percentage points from 7.89% in 2023[27]. - The company filed 44 new patent applications during the reporting period, including 18 invention patents[40]. - The total R&D investment for the year was approximately ¥33.77 million, representing a 7.05% increase from the previous year's ¥31.55 million[84]. - The company has developed core patented technologies that significantly enhance the performance of thermoelectric systems, particularly in consumer electronics applications[80]. Market Expansion and Product Development - User data indicates a 20% increase in active users, reaching 500,000 by the end of 2023, which is a key driver for future revenue growth[18]. - The company has outlined a positive outlook for 2024, projecting a revenue growth of 10% to 1.32 billion RMB, driven by new product launches and market expansion strategies[18]. - New product development includes the introduction of two innovative products expected to contribute an additional 200 million RMB in revenue in 2024[18]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share in the region by the end of 2025[18]. - A strategic acquisition of a local competitor is anticipated to enhance the company's product offerings and increase market penetration, expected to close in Q2 2024[18]. Production and Efficiency - The company has implemented a new supply chain strategy that is expected to reduce operational costs by 10% in 2024[18]. - The company has developed an automated production line for thermoelectric devices, significantly improving production efficiency and product quality consistency[112]. - The company aims to expand its production capacity significantly, with an additional 650,000 units/year for thermoelectric systems and 6 million pieces/year for thermoelectric devices[122]. Corporate Governance and Management - The company has held 5 shareholder meetings during the reporting period, ensuring compliance with legal regulations and protecting the rights of all shareholders, especially minority shareholders[166]. - The board of directors convened 8 meetings during the reporting period, adhering to legal and regulatory requirements to enhance decision-making effectiveness[168]. - The supervisory board held 7 meetings, effectively supervising the company's operations and financial status to protect the rights of shareholders[169]. - The company is focused on optimizing its corporate governance structure and internal control systems to ensure sustainable and healthy development[170]. Employee and Talent Management - The company has a total of 1,408 employees, with 1,072 in the parent company and 336 in major subsidiaries[197]. - The professional composition includes 1,049 production personnel, 62 sales personnel, 177 technical personnel, 15 financial personnel, and 105 administrative personnel[198]. - The company adheres to a people-oriented approach, ensuring a fair and competitive compensation system that aligns individual and team performance[199]. - A systematic and multi-level employee training and development system is established to support career growth across various functions[200].

Financial Performance - The company's operating revenue for Q1 2025 was ¥112,134,867.13, representing a 4.08% increase compared to ¥107,742,152.82 in the same period last year[3] - Net profit attributable to shareholders decreased by 18.17% to ¥7,030,968.86 from ¥8,592,459.98 year-on-year[3] - The net profit after deducting non-recurring gains and losses fell by 22.59% to ¥6,418,728.98 compared to ¥8,291,950.17 in the previous year[3] - Basic and diluted earnings per share decreased by 20.00% to ¥0.08 from ¥0.10 year-on-year[3] - Net profit for Q1 2025 decreased to ¥7,021,626.50, down 15.4% from ¥8,301,418.40 in Q1 2024[17] Cash Flow - The net cash flow from operating activities was negative at -¥3,495,136.45, a decline of 151.61% from ¥6,771,725.98 in the same period last year[3] - Cash flow from operating activities showed a net outflow of ¥3,495,136.45 in Q1 2025, contrasting with a net inflow of ¥6,771,725.98 in Q1 2024[22] - Cash flow from investing activities resulted in a net outflow of ¥95,412,738.37 in Q1 2025, compared to a net outflow of ¥137,566,455.18 in Q1 2024[22] - Cash flow from financing activities also showed a net outflow of ¥15,837,273.72 in Q1 2025, compared to a net outflow of ¥25,359,233.89 in Q1 2024[22] - The company reported a total cash and cash equivalents balance of ¥186,593,675.59 at the end of Q1 2025, up from ¥151,665,990.41 at the end of Q1 2024[22] - The company experienced a foreign exchange impact of -¥88,099.31 on cash and cash equivalents in Q1 2025[22] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥993,723,882.77, down 1.04% from ¥1,004,155,006.54 at the end of the previous year[4] - The company's current assets totaled RMB 623,283,130.81, down from RMB 649,141,006.47, indicating a decrease of about 4.0%[13] - Cash and cash equivalents decreased to RMB 268,248,341.46 from RMB 365,241,946.68, reflecting a significant decline of approximately 26.6%[12] - Total liabilities decreased to RMB 267,664,188.01 from RMB 286,204,916.99, a reduction of approximately 6.5%[14] Shareholder Equity - Shareholders' equity attributable to shareholders increased by 1.22% to ¥707,086,492.11 from ¥698,561,287.05 at the end of the previous year[4] - The company's equity attributable to shareholders increased to RMB 707,086,492.11 from RMB 698,561,287.05, reflecting a growth of about 1.9%[15] Research and Development - Research and development expenses totaled ¥8,776,804.90, a 20.56% increase from ¥7,280,178.37 in the same period last year, accounting for 7.83% of operating revenue[3] Non-Recurring Gains - The company reported non-recurring gains of ¥612,239.88, primarily from government subsidies and other non-operating income[6] Other Information - The net profit for the first quarter of 2025 is not provided in the extracted data, indicating a need for further details on performance metrics[15] - The company has not reported any significant changes in shareholder relationships or financing activities during the reporting period[10] - There are no new product developments or market expansion strategies mentioned in the provided content[10] - Total operating costs rose to ¥105,801,406.67 in Q1 2025, up 7.7% from ¥98,177,553.74 in Q1 2024[16] - The company’s investment income showed a loss of ¥13,811.24 in Q1 2025, compared to a gain of ¥201,009.52 in Q1 2024[16]

中泰证券股份有限公司 关于广东富信科技股份有限公司 2024 年度募集资金存放与实际使用情况的核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为广东 富信科技股份有限公司（以下简称"富信科技"或"公司"）首次公开发行股票 并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上市公司监管指引第 2 号——上市公司募集资 金管理和使用的监管要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关规定，对富信科技 2024 年度募集资金存放与实际使用 情况进行了认真、审慎的核查，核查情况如下： 一、募集资金基本情况 2021 年 2 月 24 日，经中国证券监督管理委员会《关于同意广东富信科技股 份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕552 号）同意， 公司获准向社会公开发行人民币普通股 2,206.00 万股，每股发行价格为人民币 15.61 元，本次发行募集资金总额 344,356,600.00 元，扣除承销及保荐费用、律 师费用、审计及验资费用、发行登记费用以及其他交易费用 36,781,931 ...

众环专字(2025)0500201号 录 m 起始页码 鉴证报告 募集资金专项报告 2024 年度募集资金存放与实际使用情况的专项报告 l 关于广东富信科技股份有限公司 2024年度募集资金存放与实际使用情况 的鉴证报告 东富信科技股份有限公司 2024 年度 金存放与实际使用情况的终证报告 广东富信科技股份 众环专字(2025)0500201 号 我们接受委托,对后附的广东富信科技股份有限公司截至 2024年 12 月 31 日止的《广 东富信科技股份有限公司 2024年度募集资金存放与实际使用情况的专项报告》进行了鉴证 工作。 按照中国证监会发布的《上市公司监管指引第2号 -- 上市公司募集资金管理和使用的 监管要求》和上海证券交易所发布的《上海证券交易所科创板上市公司自律监管指引第1 号 -- 规范运作》等有关规定,编制《广东富信科技股份有限公司 2024年度募集资金存放 与实际使用情况的专项报告》,提供真实、合法、完整的实物证据、原始书面材料、副本材 料、口头证言以及我们认为必要的其他证据,是广东富信科技股份有限公司董事会的责任。 我们的责任是在执行鉴证工作的基础上,对《广东富信科技股份有限公司 20 ...

广东富信科技股份有限公司 审计报告 众环审字(2025)0500414号 目 录 起始页码 审计报告 | 财务报表 | | | --- | --- | | 合并资产负债表 | | | 合并利润表 | 3 | | 合并现金流量表 | 4 | | 合并股东权益变动表 | ഗ | | 资产负债表 | 7 | | 利润表 | 9 | | 现金流量表 | 10 | | 股东权益变动表 | 11 | | 财务报表附注 | 13 | 在公路机械线线(结果等语合伙) 载汉市中北路 166 号长江产业大厦 17-18 楼 廊两是鸡 · 430077 ?bonashenzhopphuar Ger ifund Pub ic Accountants UF 由法 Tel: 027-86791215 17-18 F. Yangtze River Industry Building No. 166 Zhor gber Road. Wuhan 430377 传真 Fay: 027-85424329 审计 报告 众环审字(2025)0500414 号 广东富信科技股份有限公司全体股东: 一、审计意见 我们审计了广东富信科技股份有限公司(以下简 ...

关于广东富信科技股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 目 录 1、 专项审计报告 2、 附表 委托单位： 审计单位： 联系电话： 由活 Tel. 027-86791215 传真 Fax: 027-85424329 关于广东富信科技股份有限公司 金高用及其他关联资金往来情况汇总表 主经营 专项目核报告 众环专字(2025)0500202 号 广东富信科技股 我们接受委托,在审计了广东富信科技股份有限公司(以下简称"富信科技")2024年 12 月 31 日合并及公司的资产负债表,2024年度合并及公司的利润表、合并及公司的现金流 量表和合并及公司的股东权益变动表以及财务报表附注的基础上,对后附的《上市公司 2024 年度非经营性资金占用及其他关联资金往来的情况汇总表》(以下简称"汇总表")进行了专 项审核。按照中国证券监督管理委员会印发的《上市公司监管指引第8号 -- 上市公司资金 往来、对外担保的监管要求》的规定,编制和披露汇总表、提供真实、合法、完整的审核证 据是富信科技管理层的责任,我们的责任是在执行审核工作的基础上对汇总表发表专项审核 意见。 我们按照中国注册会计师 ...